Axogen, Inc. Financing Cash Flow
Axogen, Inc. (AXGN) reported Financing Cash Flow of $63.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-07-29
- Axogen, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $4.20M, a 262.75% increase year-over-year.
- Axogen, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $59.51M, a 2398.11% increase year-over-year.
- Axogen, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $4.57M, a 370.72% increase year-over-year.
- Axogen, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $2.39M, a 318.53% increase year-over-year.
- Axogen, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $10.50M, a 358.47% increase from fiscal 2024.
- Axogen, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $2.29M, a 17.20% increase from fiscal 2023.
- Axogen, Inc. net cash provided by (used in) financing activities for fiscal 2023 was $1.95M, a 8.92% increase from fiscal 2022.
- Axogen, Inc. net cash provided by (used in) financing activities for fiscal 2022 was $1.79M, a 91.23% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 3 month as first filed | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $4.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $63.70M 10-Q · filed 2026-07-29 | $68.27M derived: sum of 3 quarters · filed 2026-07-29 | $70.66M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2026-03-31 | $59.51M 10-Q · filed 2026-04-28 | $64.07M derived: sum of 2 quarters · filed 2026-04-28 | $66.47M derived: sum of 3 quarters · filed 2026-04-28 | $67.62M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-12-31 | $4.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $6.96M derived: sum of 2 quarters · filed 2026-02-24 | $8.12M derived: sum of 3 quarters · filed 2026-07-29 | $10.50M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $2.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $3.55M derived: sum of 2 quarters · filed 2026-07-29 | $5.93M 10-Q · filed 2025-10-29 | $6.90M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-06-30 | $1.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $3.54M 10-Q · filed 2026-07-29 | $4.51M derived: sum of 3 quarters · filed 2026-07-29 | $5.08M derived: sum of 4 quarters · filed 2026-07-29 | ||||
| 2025-03-31 | $2.38M 10-Q · filed 2026-04-28 | $3.35M derived: sum of 2 quarters · filed 2026-04-28 | $3.92M derived: sum of 3 quarters · filed 2026-04-28 | $4.47M derived: sum of 4 quarters · filed 2026-04-28 | ||||
| 2024-12-31 | $970.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.54M derived: sum of 2 quarters · filed 2026-02-24 | $2.09M derived: sum of 3 quarters · filed 2026-02-24 | $2.29M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $572.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-29 | $1.12M derived: sum of 2 quarters · filed 2025-10-29 | $1.32M 10-Q · filed 2025-10-29 | $1.74M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-05 | $748.00K 10-Q · filed 2025-08-05 | $1.17M derived: sum of 3 quarters · filed 2026-02-24 | $1.17M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $204.00K 10-Q · filed 2025-05-08 | $622.00K derived: sum of 2 quarters · filed 2026-02-24 | $627.00K derived: sum of 3 quarters · filed 2026-02-24 | $1.52M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $418.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $423.00K derived: sum of 2 quarters · filed 2026-02-24 | $1.32M derived: sum of 3 quarters · filed 2026-02-24 | $1.95M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $903.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.54M 10-Q · filed 2024-11-07 | $2.35M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-06-30 | $898.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $1.53M 10-Q · filed 2024-08-08 | $2.34M derived: sum of 3 quarters · filed 2025-02-26 | $2.56M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2023-03-31 | $633.00K 10-Q · filed 2024-05-02 | $1.45M derived: sum of 2 quarters · filed 2025-02-26 | $1.66M derived: sum of 3 quarters · filed 2025-02-26 | $2.33M derived: sum of 4 quarters · filed 2025-02-26 | ||||
| 2022-12-31 | $813.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $1.03M derived: sum of 2 quarters · filed 2025-02-26 | $1.70M derived: sum of 3 quarters · filed 2025-02-26 | $1.79M 10-K · filed 2025-02-26 | ||||
| 2022-09-30 | $215.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $886.00K derived: sum of 2 quarters · filed 2023-11-07 | $981.00K 10-Q · filed 2023-11-07 | $2.02M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-06-30 | $671.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $766.00K 10-Q · filed 2023-08-08 | $1.81M derived: sum of 3 quarters · filed 2024-03-05 | $2.61M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-03-31 | $95.00K 10-Q · filed 2023-05-09 | $1.14M derived: sum of 2 quarters · filed 2024-03-05 | $1.94M derived: sum of 3 quarters · filed 2024-03-05 | $20.03M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2021-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.85M derived: sum of 2 quarters · filed 2024-03-05 | $19.93M derived: sum of 3 quarters · filed 2024-03-05 | $20.45M 10-K · filed 2024-03-05 | ||||
| 2021-09-30 | $805.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $18.89M derived: sum of 2 quarters · filed 2022-11-08 | $19.41M 10-Q · filed 2022-11-08 | $23.92M derived: sum of 4 quarters · filed 2023-03-14 | ||||
| 2021-06-30 | $18.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $18.60M 10-Q · filed 2022-08-05 | $23.12M derived: sum of 3 quarters · filed 2023-03-14 | $23.31M derived: sum of 4 quarters · filed 2023-03-14 | ||||
| 2021-03-31 | $517.00K 10-Q · filed 2022-05-05 | $5.03M derived: sum of 2 quarters · filed 2023-03-14 | $5.22M derived: sum of 3 quarters · filed 2023-03-14 | $41.32M derived: sum of 4 quarters · filed 2023-03-14 | ||||
| 2020-12-31 | $4.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $4.71M derived: sum of 2 quarters · filed 2023-03-14 | $40.80M derived: sum of 3 quarters · filed 2023-03-14 | $40.47M 10-K · filed 2023-03-14 | ||||
| 2020-09-30 | $191.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $36.29M derived: sum of 2 quarters · filed 2021-11-04 | $35.96M 10-Q · filed 2021-11-04 | $36.87M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $36.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $35.77M 10-Q · filed 2021-08-05 | $36.68M derived: sum of 3 quarters · filed 2022-02-25 | $37.30M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | -$328.00K 10-Q · filed 2021-05-06 | $585.00K derived: sum of 2 quarters · filed 2022-02-25 | $1.21M derived: sum of 3 quarters · filed 2022-02-25 | $3.38M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $913.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $1.53M derived: sum of 2 quarters · filed 2022-02-25 | $3.71M derived: sum of 3 quarters · filed 2022-02-25 | $4.03M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $620.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-30 | $2.79M derived: sum of 2 quarters · filed 2020-10-30 | $3.12M 10-Q · filed 2020-10-30 | $4.21M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-06-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $2.50M 10-Q · filed 2020-08-07 | $3.60M derived: sum of 3 quarters · filed 2021-03-01 | $4.45M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2019-03-31 | $325.00K 10-Q · filed 2020-05-06 | $1.42M derived: sum of 2 quarters · filed 2021-03-01 | $2.28M derived: sum of 3 quarters · filed 2021-03-01 | $109.77M derived: sum of 4 quarters · filed 2021-03-01 | ||||
| 2018-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $1.95M derived: sum of 2 quarters · filed 2021-03-01 | $109.44M derived: sum of 3 quarters · filed 2021-03-01 | $109.84M 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $856.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $108.35M derived: sum of 2 quarters · filed 2019-11-06 | $108.75M 10-Q · filed 2019-11-06 | $108.75M 10-Q · filed 2018-10-29 | $124.75M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $107.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $107.89M 10-Q · filed 2019-08-06 | $107.89M 10-Q · filed 2018-08-01 | $123.90M derived: sum of 3 quarters · filed 2020-02-24 | $124.51M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-03-31 | $399.00K 10-Q · filed 2019-05-08 | $398.71K 10-Q · filed 2018-04-30 | $16.41M derived: sum of 2 quarters · filed 2020-02-24 | $17.02M derived: sum of 3 quarters · filed 2020-02-24 | $17.38M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $16.01M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $16.62M derived: sum of 2 quarters · filed 2020-02-24 | $16.99M derived: sum of 3 quarters · filed 2020-02-24 | $17.02M 10-K · filed 2020-02-24 | $17.02M 10-K · filed 2018-02-28 | |||
| 2017-09-30 | $611.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $978.46K derived: sum of 2 quarters · filed 2018-10-29 | $1.02M 10-Q · filed 2018-10-29 | $16.87M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $366.81K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $403.54K 10-Q · filed 2018-08-01 | $16.26M derived: sum of 3 quarters · filed 2019-02-26 | |||||
| 2017-03-31 | $36.73K 10-Q · filed 2018-04-30 | $15.89M derived: sum of 2 quarters · filed 2019-02-26 | ||||||
| 2016-12-31 | $15.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $16.50M 10-K · filed 2019-02-26 | $16.50M 10-K · filed 2018-02-28 | |||||
| 2016-09-30 | $645.86K 10-Q · filed 2017-11-01 | |||||||
| 2015-12-31 | $31.30M 10-K · filed 2018-02-28 | |||||||
| 2013-09-30 | $16.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $16.86M derived: sum of 2 quarters · filed 2013-10-30 | $16.86M 10-Q · filed 2013-10-30 | $29.70M derived: sum of 4 quarters · filed 2013-10-30 | ||||
| 2013-06-30 | $31.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $33.39K 10-Q · filed 2013-08-14 | $12.88M derived: sum of 3 quarters · filed 2013-08-14 | $14.55M derived: sum of 4 quarters · filed 2013-10-30 | ||||
| 2013-03-31 | $1.65K 10-Q · filed 2013-04-30 | $12.85M derived: sum of 2 quarters · filed 2013-08-07 | $14.51M derived: sum of 3 quarters · filed 2013-10-30 | $14.51M derived: sum of 4 quarters · filed 2013-10-30 | ||||
| 2012-12-31 | $12.84M derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-07 | $14.51M derived: sum of 2 quarters · filed 2013-10-30 | $14.51M derived: sum of 3 quarters · filed 2013-10-30 | $14.51M 10-K/A · filed 2013-08-07 | ||||
| 2012-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | $1.66M derived: sum of 2 quarters · filed 2013-10-30 | $1.66M 10-Q · filed 2013-10-30 | $1.55M derived: sum of 4 quarters · filed 2013-10-30 | ||||
| 2012-06-30 | -$7.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$7.54K 10-Q · filed 2013-08-14 | -$117.71K derived: sum of 3 quarters · filed 2013-08-14 | $3.43M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $4.00 10-Q · filed 2013-04-30 | -$110.16K derived: sum of 2 quarters · filed 2013-08-07 | $3.44M derived: sum of 3 quarters · filed 2013-08-07 | $6.40M derived: sum of 4 quarters · filed 2013-08-07 | ||||
| 2011-12-31 | -$110.16K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-07 | $3.44M derived: sum of 2 quarters · filed 2013-08-07 | $6.40M derived: sum of 3 quarters · filed 2013-08-07 | $6.36M 10-K/A · filed 2013-08-07 | ||||
| 2011-09-30 | $3.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $6.51M derived: sum of 2 quarters · filed 2012-11-06 | $6.47M 10-Q · filed 2012-11-06 | $8.78M derived: sum of 4 quarters · filed 2012-11-06 | ||||
| 2011-06-30 | $2.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $2.92M 10-Q · filed 2012-08-14 | $5.23M derived: sum of 3 quarters · filed 2012-08-14 | $12.71M derived: sum of 4 quarters · filed 2012-08-14 | ||||
| 2011-03-31 | -$37.35K 10-Q · filed 2012-05-15 | $2.28M derived: sum of 2 quarters · filed 2012-05-15 | $9.75M derived: sum of 3 quarters · filed 2012-05-15 | |||||
| 2010-12-31 | $2.31M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-15 | $9.79M derived: sum of 2 quarters · filed 2012-03-15 | $5.53M 10-K · filed 2012-03-15 | |||||
| 2010-09-30 | $7.48M derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-14 | $3.22M 10-Q · filed 2011-11-14 | ||||||
| 2010-06-30 | -$4.26M 10-Q/A · filed 2011-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |